Vulva carcinoma. Diagnosis and therapy;Vulvakarzinom. Diagnostik und therapie

Gynakologe

Volumn 32, Issue 11, 1999, Pages 879-888

  Schnurch H G ^a   Pfleiderer, A ^b  

^a Lukaskrankenhaus GmbH   (Germany)

^b Frauenklinik des Lukaskrankenhauses ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER STAGING; CONDYLOMA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PAPILLOMA VIRUS; REVIEW; VULVA CARCINOMA; VULVECTOMY;

EID: 0037533112     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00003194     Document Type: Review

References (57)

1. Ambros RA, Malfetano JH, Mihm Jr MC (1996) Clinicopathologic features of vulvar squamous cell carcino-mas exhibiting prominent fibromyxoid stromal response. Int J Gynecol Pathol 15:137-145
2. Bancher-Todesca D, Obermair A, Bilgi S, Kohlberger R Kainz C, Breitenecker G, Leodolter S, Gitsch G (1997) Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol 64:496-500
3. BenDavid Y, Lickrish GM, Rosen BP, Murphy JK, Walters M, DePetrillo D (1996) Vulvar intraepithelial neoplasia-treatment outcome. Int J Gynecol Cancer 6:145-148
4. Bender HG (1991) Tumoren der Vulva. In Bender HG (Hrg) Gynäkologische Onkologie.Thieme Stuttgart New York, 2 Aufl, S 335-346
5. Boronow RC, Hickman BT, Reagan MT( 1987) Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J din Oncol 10:171
6. Burger MPM, Hollema H, Bouma J ( 1996) The side of groin node metastases in unilateral vulvar carcinoma, Int J Gyriecol Cancer 6:318-322
7. Collins CG, Hansen LH, Theriot E (1966) A clinical stain for use in selecting biopsy sites in patients with vulvar diseases. Obstet and Gynec 28:158
8. Cavanagh D ( 1997) Vulvar cancer - continuing evolution in management. Gynecol Oncol 66:362-367
9. Cunningham MJ, Goyer RP, Gibbons SK, Kredentser DC, Malfetano JH, Keys H (1997) Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 66:258-261
10. DeCesare SL, Fiorica J V, Roberts WS, Reintgen D, Arango H, Huffman, MS, Puleo C, Cavanagh D (1997) A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 66:425-428
11. DePasquale SE, McGuinness TB, Mangan CE, Husson M, Woodland MB (1996) Adenoid cystic carcinoma of Bartholin's gland: a review of the literature and report of a patient. Gynecol On col 61:122-125
12. Feakins RM,Lowe DG (1997) Basal cell carcinoma of the vulva. A clinicopathologic study of 45 cases, Int J Gynecol Pathol 16:319-324
13. Flam F, Larson B (1997) Adenoid cystic carcinoma of Bartholin's gland: a review of the literature and report of a patient with widespread metastases to the bone, Int J Gynecol Cancer 7:458-460
14. Gordinier ME, Steinhoff MM, Hogan JW, Peipert JF, Gajewski WH, Falkenberry SS, Granai CO (1997) Sphase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancer. Gynecol Oncol 67:200-202
15. Hacker NF, Berek JS (1990) Vulva. In: Haskell CM (ed) Cancer Treatment. 3rd ed Philadelphia, Saunders, pp 351-361
16. Hacker NF (1994) Vulvar Cancer. In: Berek, JS, Hacker NF (eds): Practical Gynecologic Oncology. 2nd ed Baltimore,Williams & wilkins pp 403-439
17. Heaps JM, Fu YS, Montz FJ (1990) Surgicalpathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38:309
18. Hillemanns HG, Schillinger H, Hilgarth M, Schmidt-Matthiesen H (1991) Präneoplasien und Neoplasien der Vulva. In: Schmidt-Matthiesen,H (ed) Klinik der Frauenheilkunde und Geburtshilfe Band 11:49-104, Urban & Schwarzenberg, München, 3Aufl
19. Homesley HD, Bundi BN,Sedlis A, Adcock L (1986) Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68:733
20. Homesley HD, Bundi BN, Sedlis A,Yardan E, Berek JS, Jashan A (1991) Assessment of current international federation of gynecology and obstetrics staging of vulvar carcinoma relative tu prognostic factors for survival (a GOG Group study). Am J Obstet Gynecol 164:997-1004
21. HordingU,Daugaard S, Junge J, Lundvall F (1996) Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol 15:230-234
22. Ikenbercj H, Schwörer D, Pfleiderer A (1988) Nachweis von humaner Papilloma-virus(HPV)-DNA in Vulvakarzinomen. Geburtsh und Frauenheilhk 48:776-779
23. Johnson GA, Mannell R, Khalifa M, Walker JL, Wren M, Min KW, Benbbrook DM (1997) Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol 65:425-429
24. Kagie MJ, Kenter GG, Tollenaar RAEM, Hermans J, Trimbos JB, Fleuren GJ (1997) p53 protein over-expression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter, Int J Gynecol Pathol 16:124-130
25. Kagie MJ, Kenter GG, Zomerdijk-Nooijen Y, Hermans J, Schuuring E, Timmers PJ, Trimbos JB, Fleuren GJ (1997) Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin. Gynecol Oncol 67:178-183
26. Knapstein PG, Friedberg V (1987) Plastische Operationen an der Vulva und Vagina. In: Knapstein PG et al (eds) Plastische Chirurgie in der Gynäkologie.Thieme Stuttgart New York, S 73-128
27. Kürzl R, Messerer D (1989) Prognostic factors in squamous cell carcinoma of the vulva: a multivariate analysis. Gynecol Oncol 32:143-150
28. Landoni F, Maneo A, Zanetta G, Colombo A, Nava S, Placa F, Tancini G, Mangioni C (1996) Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 61:321-327
29. Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JW Wharton JT (1996) Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol 62:73-77
30. Leiserowitz GS, Russell AH, Kinney WK, Smith LH, Taylor MH, Scudder SA (1997) Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol 66:509-514
31. Lucas WE (1981) Die stadienangepaßte Therapie des Vulvakarzinoms. Gynäkologe 14:150-158
32. Manahan KJ, Hudec J, Fanning J (1997) Modified radical vulvectomy without lymphadenectomy under local anesthesia in medically compromised patients. Gynecol Oncol 67:166-167
33. McConnell DT, WilsonBJ, Russell D, Parkin DE, Kitchener HC (1996) Rising incidence of vulval cancer in North East Scotland 1974-1994: a population based study, Int J Gynecol Cancer 6:309-312
34. Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Leodolter S, Reintaller A, Kainz C, Breitenecker G, Gitsch G (1996) Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63:204-209
35. Paley PJ, Johnson PR, Adcock LL, Cosin JA, Chen MD, Fowler JM, Twiggs LB, Carson LF (1997) The effect of Sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. Gynecol Oncol 64:237-241
36. Petry KU, Köchel H, Bode U, Schedel I, Niesert S, Glaubitz M, Maschiek H, Kühnle H (1996) Human papillomavirus is associated with the frequent detection of warty and basaloid highgrade neoplasia among immune-compromised women. Gynecol Oncol 60:30-34
37. Pettersson F (ed) (1994) Annual Report on the results of treatment in gynecological cancer. Vol 22. Editorial Office, Radiumhemmet, Stockholm
38. Pfleiderer A (1986) Zytostatische Therapie des Vulvakarzinoms. In:Zander J, Baltzer J (eds) Erkrankungen der Vulva. Urban & Schwarzenberg München, S 174-184
39. Robboy SJ, Bentley RC, Krigman H, Silverberg SG, Norris HJ, Zaino RJ (1994) Synoptic reports in gynecologic pathology, Int J Gynecol Pathol 13:161-174
40. Rodriguez M, Sevin BU, Averette HE, Angioli R, Janicek M, Method M,Penalver A (1997) Conservative trends in the surgical management of vulvar cancer: a University of Miami patient care evaluation study, Int J Gynecol Cancer 7:151-157
41. Rosen C, Malmström H (1997) Invasive cancer of the vulva. Gynecol Oncol 65:213-217
42. Sagerman PM, Choi YJ, Hu Y, Niedt GW (1996) Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva. Gynecol Oncol 61:328-332
43. Scheistroen M, Tropé C, Kaern J, Abeler VM, Pettersen EO, Kristensen GB (1996) Malignant melanoma of the vulva FIGO stage I: evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment. Gynecol Oncol 61:253-258
44. Schnürch H-G, Küppers V (1996) Therapie bei VIN 3 - standardisiert oder individuell? Zentralbl Gynäkol 118:345-349
45. Schnürch H-G, Küppers V, Bender HG (1997) VuLva-Neoplasien. In: Onkologie - Grundlagen, Diagnostik, Therapie, Entwicklungen. Band 2 Zeller WJ,zur Hausen H (Hrg), ecomed Landsberg, 3. Ergänzungsl;V-2.11,S1-9
46. Schnürch H-G (1999) Vorsorgeuntersuchung der weiblichen Genitalorgane. In: Spezielle gynäkologische Onkologie I. Bd. 11. Bender HG (Hrg). Klinik der Frauenheilkunde u. Geburtshilfe 4 Aufl Bender HG, Künzel W, Diedrich K (Hrg), U &S München,im Druck
47. Scurry J, Vanin K, Östör A (1997) Comparison of histological features of vulvar liehen sclerosis with and without adjacent squamous cell carcinoma, Int J Gynecol Cancer 7:392-399
48. Sun Y, Hildesheim A, Brinton LA, Nasca PC, trimble CL,Kurman RJ, Viscidi RRShah KV (1996) Human papillomavirus-specific serologie responses in vulvar neoplasia. Gynecol Oncol 63: 200-203
49. Tateo A, Tateo S, Bernasconi C,Zara C (1996) Use of V-Y flap for vulvar reconstruction. Gynecol Oncol 62:203-207
50. Toki T, Kurman RJ, Park JS, Kessis T, Daniel RW, Shah KV (1991) Probable nonpaillomavirus etiology of squamous cell carcinoma of the vulva in older women: A clinicopathologic study using in situ hybridisation and polymerase chain reaction, Int J Gynecol Pathol 10:107-125
51. VanBeurden M, tenKate FW, Tjong-A-Hung SP, deCraen M, van der Vange N, Lammes FB, terSchegget J (1998) Human papillomavirus DANN in multicentric vulvar intraepithelial neoplasia. Int J Gynecol Pathol 17:12-16
52. VanderVelden J, vanLindert ACM, Gimbrere CHF, Oosting H, Heintz APM (1996) Epidemiologic data on vulvar cancer: Comparison of hospital with population based data. Gynecol Oncol 62:379-383
53. VanderZee AGJ, deHullu J, Aalders JG, Boonstra H, Piers DA (1997) Identification of sentinel node by lymphoscintigraphy in patients with vulvar cancer. Abstract, Int J Gynecol Cancer 7,Suppl 2:83
54. Vilmer C, Cavelier-Balloy B, Nogues C, Trassard M, LeDoussal V (1998) Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a stuy of 67 cases. Europ J Gynecol Oncol 19:25-31
55. Weghaupt K (1986) Vulvakarzinom-Elektroresektion und Elektrokoagulation der Vulva -(Wiener Methode). In: Zander J, Baltzer J (eds) Erkrankungen der Vulva. Urban & Schwarzenberg, München, S 150-160
56. Wilkinson EJ (1994) Premalignant and Malignant Tumors of the Vulva. In Kurman RJ (ed) Blaustein's Pathology of the Female Genital Tract Berlin Heidelberg New York, Springer, pp 87-129
57. Wilkinson EJ, Rico MJ, Pierson KK (1982) Microinvasive carcinoma of the vulva, Int J Gynecol Pathol 1:29-39